Status:
COMPLETED
Anxiety and Depression In Patients With Obstructive Sleep Apnoea Before and After Continuous Positive Airway Pressure
Lead Sponsor:
Universidad de Granada
Collaborating Sponsors:
University Hospital Virgen de las Nieves
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Continuous positive airway pressure (CPAP) is the gold-standard treatment for obstructive sleep apnoea (OSA), the most common sleep-disordered breathing in the overall population. CPAP has shown to be...
Eligibility Criteria
Inclusion
- Previous clinical diagnosis of mild/moderate/severe OSA (AHI \> 5) by a healthcare professional
- Use of CPAP
- Motivation to participate in the study
- Willing to provide informed consent
Exclusion
- Presence of any other primary sleep disorder
- Presence of any mental disorder (including depression, anxiety, and addiction to alcohol or other substances)
- Presence of any other severe organic disease, except for those comorbid to OSA
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 14 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04104880
Start Date
April 1 2019
End Date
October 14 2019
Last Update
September 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Granada
Granada, Spain, 18011